Literature DB >> 7596842

Enhancement of retrovirus-mediated gene transduction efficiency by transient overexpression of the amphotropic receptor, GLVR-2.

S Yamaguchi1, H Wakimoto, Y Yoshida, Y Kanegae, I Saito, M Aoyagi, K Hirakawa, T Amagasa, H Hamada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7596842      PMCID： PMC306989          DOI： 10.1093/nar/23.11.2080

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  7 in total

1.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

2.  A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family.

Authors:  M van Zeijl; S V Johann; E Closs; J Cunningham; R Eddy; T B Shows; B O'Hara
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

3.  Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas.

Authors:  F Momose; T Araida; A Negishi; H Ichijo; S Shioda; S Sasaki
Journal:  J Oral Pathol Med       Date:  1989-08       Impact factor: 4.253

4.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Authors:  G Dranoff; E Jaffee; A Lazenby; P Golumbek; H Levitsky; K Brose; V Jackson; H Hamada; D Pardoll; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome.

Authors:  I Saito; Y Oya; K Yamamoto; T Yuasa; H Shimojo
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  Identification and characterization of autocrine-motility-factor-like activity in oral squamous-cell-carcinoma cells.

Authors:  A Ishisaki; S Oida; F Momose; T Amagasa; K Rikimaru; H Ichijo; S Sasaki
Journal:  Int J Cancer       Date:  1994-12-15       Impact factor: 7.396

7.  Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2.

Authors:  Y Nakamura; H Wakimoto; J Abe; Y Kanegae; I Saito; M Aoyagi; K Hirakawa; H Hamada
Journal:  Cancer Res       Date:  1994-11-15       Impact factor: 12.701
  7 in total
  5 in total

1.  A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites.

Authors:  P J Valk; M Joosten; Y Vankan; B Löwenberg; R Delwel
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

2.  Selective transduction of HIV-1-infected cells by the combination of HIV and MMLV vectors.

Authors:  Noriyasu Sakai; Koichi Miyake; Noriko Suzuki; Takashi Shimada
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

3.  Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Natsuo Ohsawa; Kiminori Nakamura; Hirofumi Hamada; Hidefumi Furuoka; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

4.  Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: comparison of adenovirus- and retrovirus-mediated genetic transduction.

Authors:  J Abe; H Wakimoto; Y Yoshida; M Aoyagi; K Hirakawa; H Hamada
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

5.  Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy.

Authors:  H Wakimoto; Y Yoshida; M Aoyagi; K Hirakawa; H Hamada
Journal:  Jpn J Cancer Res       Date:  1997-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.